The High Intensity Focused Ultrasound Market is Predict to reach USD 1.9 Billion by 2031, at a CAGR of 7.1%

High Intensity Focused Ultrasound Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global High Intensity Focused Ultrasound Market size is expected to reach $1.9 billion by 2031, rising at a market growth of 7.1% CAGR during the forecast period.

The expansion of the high intensity focused ultrasound market is driven by its advantages as a non-invasive, precise treatment option for various medical conditions, including uterine fibroids, prostate cancer, and tumours. Technological advancements have enhanced its efficacy and safety while increasing patient preference for minimally invasive procedures, and growing awareness among healthcare providers contributes to its adoption. Additionally, rising healthcare investments and improved access in developed and emerging markets, particularly in North America and Asia-Pacific, support market growth.

The Hospital segment is leading the Global High Intensity Focused Ultrasound Market by End Use in 2023; thereby, achieving a market value of $684.8 million by 2031. Hospitals are equipped with the advanced technology and infrastructure necessary for HIFU procedures. This includes sophisticated imaging systems and specialized HIFU machines that are crucial for the precision and effectiveness of the treatment. Hospitals are often the setting for complex and severe cases that may require the advanced capabilities of HIFU.

The Uterine Fibroids segment is registering a CAGR of 6% during (2024 - 2031). HIFU can be used for focal treatment, targeting only the cancerous areas within the prostate while leaving non-cancerous areas intact. This approach is especially appealing for patients with localized prostate cancer who wish to preserve as much of the prostate as possible. For patients with recurrent prostate cancer after previous treatments, HIFU offers a potential option to manage localized recurrences without additional systemic therapies or invasive procedures.

Full Report: https://www.kbvresearch.com/high-intensity-focused-ultrasound-market/

The North America region dominated the Global High Intensity Focused Ultrasound Market by Region in 2023; thereby, achieving a market value of $681.9 million by 2031. The Europe region is anticipated to grow at CAGR of 6.8% during (2024 - 2031). Additionally, The Asia Pacific region would witness a CAGR of 7.7% during (2024 - 2031).

List of Key Companies Profiled

• EDAP TMS S.A
• Sonablate Corp.
• Verasonics, Inc.
• ALPINION MEDICAL SYSTEMS Co., Ltd.
• Theraclion
• Lynton Lasers Ltd
• ULTRAISER
• PROFOUND MEDICAL CORP.

High Intensity Focused Ultrasound Market Report Segmentation

By End Use

• Hospital
• Imaging Centers
• Others

By Application

• Dermatology
• Uterine Fibroids
• Prostate Cancer
• Essential Tremor
• Breast Cancer
• Glaucoma
• Backpain, Facetogenic
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Related Reports:

North America High Intensity Focused Ultrasound Market Size 2031

• September-2024
• 70 Pages

LAMEA High Intensity Focused Ultrasound Market Size 2031

• September-2024
• 77 Pages

Europe High Intensity Focused Ultrasound Market Size 2031

• September-2024
• 75 Pages

Asia Pacific High Intensity Focused Ultrasound Market Size 2031

• September-2024
• 79 Pages